Advita Ortho, LLC

Based in the US, Advita Ortho, LLC specializes in advanced orthopedic solutions, focusing on the development and manufacturing of orthopedic implants and surgical technologies for joint replacement surgeries. Advita Ortho, LLC, founded in 2025, is headquartered in Gainesville, US, and is dedicated to providing innovative orthopedic solutions. The company is known for a single transaction in its history, with its most recent deal occurring on January 12, 2026. The CEO is Aurelio Sahagun, and the venture operates independently without any known parent or subsidiaries.

Advita Ortho specializes in the development and manufacturing of advanced orthopedic implants and surgical technologies. Their core product offerings include innovative shoulder implants for both primary and reverse total shoulder arthroplasties (TSA), as well as transformative knee and hip replacement solutions, including total knee arthroplasties (TKA) and total hip arthroplasties (THA). Additionally, the company offers a pioneering GPS navigation system powered by artificial intelligence (AI), which enhances preoperative planning and intraoperative guidance for knee, shoulder, and ankle surgeries. Advita's products are designed to address critical use cases in joint replacement surgery, focusing on improving surgical outcomes and enhancing recovery for patients.

The company serves a global client base including healthcare professionals and surgical centers across markets such as the United States, Australia, Germany, France, Japan, and several others throughout Europe and Asia. Advita Ortho's revenue is derived from the sale of orthopedic implants and associated surgical technologies, primarily through direct transactions with healthcare providers and surgical centers. The company operates on a business-to-business (B2B) model, where hospitals and orthopedic practices purchase their innovative products, including their flagship offerings such as the GPS navigation systems and advanced implant technologies. These transactions are structured as direct sales agreements, under which customers order products based on their specific needs and inventory levels.

Pricing for these products is aligned with the premium nature of their technology and design, focusing on providing value through enhanced surgical precision and improved patient outcomes. The firm maintains a strong emphasis on ongoing partnerships with healthcare professionals to ensure effective implementation and utilization of their solutions. In January 2026, Advita Ortho secured a USD 35 million senior secured revolving credit facility from Wingspire Capital. This financing will support the company in broadening and enhancing the sales of its established product offerings.

Advita aims to expand its technological portfolio with upcoming product launches, although specific new products and release dates are not detailed. The company is also exploring opportunities to penetrate new markets, including increased focus on regions in Europe and Asia, as part of its strategic growth initiative.